LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 61.56 | 27.76 | 1238 | 6217 | 0.1991 | 0.6265 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 61.56 | 27.76 | 1359 | 6217 | 0.2186 | 0.6461 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 61.56 | 27.76 | 1392 | 6217 | 0.2239 | 0.6511 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.26 | 27.76 | 1178 | 6465 | 0.1822 | 0.6106 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.26 | 27.76 | 1211 | 6465 | 0.1873 | 0.6163 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.26 | 27.76 | 1356 | 6465 | 0.2097 | 0.6397 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.26 | 27.76 | 1386 | 6465 | 0.2144 | 0.6443 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 64.97 | 27.76 | 1095 | 6656 | 0.1645 | 0.5918 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 64.97 | 27.76 | 1220 | 6656 | 0.1833 | 0.6137 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 64.97 | 27.76 | 1335 | 6656 | 0.2006 | 0.6322 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 64.97 | 27.76 | 1383 | 6656 | 0.2078 | 0.6395 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 66.67 | 27.76 | 1179 | 6695 | 0.1761 | 0.6059 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 66.67 | 27.76 | 1226 | 6695 | 0.1831 | 0.6139 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 66.67 | 27.76 | 1371 | 6695 | 0.2048 | 0.6368 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 66.67 | 27.76 | 1406 | 6695 | 0.2100 | 0.6420 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 68.37 | 27.76 | 1202 | 6879 | 0.1747 | 0.6061 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 68.37 | 27.76 | 1243 | 6879 | 0.1807 | 0.6129 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 68.37 | 27.76 | 1367 | 6879 | 0.1987 | 0.6323 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 68.37 | 27.76 | 1401 | 6879 | 0.2037 | 0.6373 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 70.08 | 27.76 | 1170 | 6849 | 0.1708 | 0.6012 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 70.08 | 27.76 | 1238 | 6849 | 0.1807 | 0.6127 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 70.08 | 27.76 | 1375 | 6849 | 0.2007 | 0.6341 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 70.08 | 27.76 | 1401 | 6849 | 0.2045 | 0.6380 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 71.78 | 27.76 | 1170 | 6893 | 0.1697 | 0.6004 | MN20160318_Q01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 71.78 | 27.76 | 1224 | 6893 | 0.1776 | 0.6095 | MN20160318_Q01 | L03 |